Kyongbo Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Kyongbo Pharmaceutical Co Ltd with three other
companies in this sector in South Korea:
CKD Bio Corp
sales of 118.19 billion Korean Won [US$110.98 million]
(177.77 billion Korean Won [US$166.93 million]
of which 91%
was Medicine), and
(144.44 billion Korean Won [US$135.63 million]
During the year ended December of 2017, sales at
Kyongbo Pharmaceutical Co Ltd were 191.66 billion Korean Won (US$179.97 million).
increase of 2.6%
versus 2016, when the company's sales were 186.73 billion Korean Won.
This was the fifth consecutive year of sales increases at Kyongbo Pharmaceutical Co Ltd
(and since 2012, sales have increased a total of 25%).